Traditional surgical approaches to uterine fibroids: Abdominal myomectomy and hysterectomy

Clinical Obstetrics and Gynecology

Volumn 44, Issue 2, 2001, Pages 385-400

  Guarnaccia, Michael M ^a   Rein, Mitchell S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GOSERELIN; IRON; LEUPRORELIN;

BLEEDING; CLINICAL FEATURE; CLINICAL TRIAL; CONCEPTION; COUNSELING; DRUG INDUCED DISEASE; FEMALE INFERTILITY; HEALTH CARE COST; HORMONAL THERAPY; HOSPITALIZATION; HUMAN; HYSTERECTOMY; MALIGNANT TRANSFORMATION; MYOMECTOMY; POSTMENOPAUSE; POSTOPERATIVE COMPLICATION; PREGNANCY RATE; PREMENOPAUSE; PREOPERATIVE EVALUATION; REPRODUCTION; REVIEW; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT INDICATION; TUMOR VOLUME; UTERUS MYOMA;

BLOOD LOSS, SURGICAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYSTERECTOMY; INFERTILITY, FEMALE; LEIOMYOMA; PREOPERATIVE CARE; UTERINE NEOPLASMS;

EID: 0035033701     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200106000-00024     Document Type: Review

References (51)

1. The frequency of uterine leiomyomas
2. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis of glucose-6-phosphate dehydrogenase
3. Cytogenetic abnormalities in uterine leiomyomata
4. Cytogenetics abnormalities in uterine myomas are associated with myoma size
5. Plasma growth hormone and estradiol levels in women with uterine myomas
6. Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata
7. The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin releasing hormone agonist
8. Appropriateness of hysterectomies performed for multiple preoperative indications
9. The Maine Women's Health Study: I. Outcomes of hysterectomy
10. Routine hysterectomy for large asymptomatic uterine leiomyomata: A reappraisal
11. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma
12. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States
13. Complications after hysterectomy. A Danish population-based study 1978-1983
14. Uterine leiomyomata: Etiology, symptomatology, and management
15. Abdominal myomectomy in the treatment infertility
16. Myomectomy: A retrospective study to examine reproductive performance before and after surgery
17. Pregnancy success following abdominal myomectomy for infertility
18. Abdominal myomectomy and subsequent fertility
19. Determinants of reproductive outcome after abdominal myomectomy for infertility
20. Submucosal leiomyomas and infertility
21. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment
22. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: Results of a matched follow-up study
23. Effect of uterine leiomyomata on the results of in vitro fertilization treatment
24. Uterine myomata and outcome of assisted reproduction
25. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent abortion
26. Myomectomy for fertility enhancement and preservation
27. High-field MRI and U/S evaluation of the pelvis in women with leiomyomas
28. Enlarged uterus: Differentiation between adenomyosis and leiomyoma with MR imaging
29. Monitoring therapy with a gonadotropin-releasing hormone analog: Utility of MR imaging
30. Transabdominal sonohysterography, transvaginal sonography, and hysteroscopy in the evaluation of submucous myomas
31. Abdominal hysterectomy or abdominal myomectomy for symptomatic leiomyoma: A comparison of preoperative demography and postoperative morbidity
32. Myomectomy as a reproductive procedure
33. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas
34. Morbidity associated with abdominal myomectomy
35. Recurrence of fibroids after myomectomy: A transvaginal ultrasonographic study
36. Risk of recurrence after myomectomy
37. Treatment with GnRH agonists before myomectomy and the risk of short-term recurrence
38. Recurrence of myomas after myomectomy in women pretreated with leuprolide acetate depot or placebo
39. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata
40. Long-term medical therapy for leiomyomata uteri: A prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin add-back for two years
41. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: A randomized, controlled trial
42. The place of Zoladex in deferred surgery for uterine fibroids
43. A prospective randomized study to evaluate leuprolide acetate treatment before myomectomy: Efficacy and ultrasonographic predictors
44. Decrease in symptoms, blood loss, and uterine size with naferelin-acetate before abdominal hysterectomy: A placebo-controlled, double-blind study
45. Treatment with the gonadotropin-releasing hormone agonist goserelin before hysterectomy for uterine fibroids
46. Use of GnRH agonist before hysterectomy: A cost simulation
47. Gonadotropin-releasing hormone agonist use before hysterectomy
48. The effect of operative technique and uterine size on blood loss during myomectomy: A prospective randomized study
49. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy
50. Vaginal hysterectomy by uterine morcellation: An efficient, nonmorbid procedure
51. Costs and charges associated with alternative techniques of hysterectomy